Literature DB >> 11749742

Surveillance for antimicrobial resistance in Croatia.

Arjana Tambic Andrasevic1, Tera Tambic, Smilja Kalenic, Vera Jankovic.   

Abstract

We describe the activities of the Croatian Committee for Antibiotic Resistance Surveillance and report surveillance results for 1999. Twenty-two Croatian microbiology laboratories participated in the study. Resistance rates for the organisms isolated in different centers varied widely, but certain trends were apparent. Penicillin resistance in pneumococci (38%), methicillin resistance in Staphylococcus aureus (22%), the production of extended spectrum beta-lactamases by Klebsiella pneumoniae (21%), and imipenem resistance in Pseudomonas aeruginosa (11%) represent major resistance problems, especially in large hospitals. A comprehensive system of antimicrobial resistance surveillance, combined with training and external quality control programs, has identified high rates of resistance in key pathogens in some regions of Croatia. The program has heightened awareness of the problems of antimicrobial resistance and contributed to ongoing improvements in laboratory practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11749742

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  4 in total

1.  Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carriage in women from former Yugoslavia living in Switzerland.

Authors:  J Marschall; P Dürig; K Mühlemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

2.  Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.

Authors:  Igor Francetić; Smilja Kalenić; Mirjana Huić; Iveta Mercep; Ksenija Makar-Ausperger; Robert Likić; Viktorija Erdeljić; Vesna Tripković; Petra Simić
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

3.  Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.

Authors:  Marija Guzvinec; Radosław Izdebski; Iva Butic; Marko Jelic; Maja Abram; Iva Koscak; Anna Baraniak; Waleria Hryniewicz; Marek Gniadkowski; Arjana Tambic Andrasevic
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

4.  Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia.

Authors:  Sanda Sardelic; Lucia Pallecchi; Volga Punda-Polic; Gian Maria Rossolini
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.